‘Les liaisons dangereuses’: Hepatitis C, Rituximab and B-cell non-Hodgkin’s lymphomas

Rituximab has provided a revolutionary contribution to the treatment of B-cell non-Hodgkin’s lymphomas (NHL). A high prevalence of hepatitis C virus (HCV) infection has been described in B-cell NHL patients. Cases of liver dysfunction in HCV-positive patients have been reported with Rituximab-contai...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	World journal of gastrointestinal pharmacology and therapeutics 2012-04, Vol.3 (2), p.21-28
Hauptverfasser:	Marignani, Massimo, Fonzo, Michela di, Begini, Paola, Gigante, Elia, Deli, Ilaria, Pellicelli, Adriano M, Gallina, Sara, de Santis, Emanuela, Delle Fave, Gianfranco, Cox, M Christina
Format:	Artikel
Sprache:	eng
Schlagworte:	lymphoma Hepatitis non-Hodgkin’s Rituximab B-cell Topic Highlight virus Immunochemotherapy Methodology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!